Dermatology

When hemangioma indicates PHACE risk

June 21, 2021

Not all infants with infantile hemangiomas are at risk of PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome, but some characteristics may indicate an increased risk.

FDA approves Cosentyx for kids aged 6 and older

June 02, 2021

The US Food and Drug Administration (FDA) approved Cosentyx® (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older. It’s the first pediatric approval for the drug.